PEGDA Hydrogel-Shell Capsules for Multi-Step Cell Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for encapsulating biological samples in semi-permeable capsules fail to support multi-step reactions and analysis, such as genotypic and phenotypic analysis of individual cells, due to limitations in fluidic operations and the inability to perform buffer/reagent exchange.
Innovation Solution
The production of semi-permeable capsules with a Dextran-rich core and PEGDA-based hydrogel shell, formed through microfluidics and photo-illumination, allows for multi-step processing and analysis of encapsulated species like cells and nucleic acids, enabling buffer exchange and retention of encapsulated entities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If droplet or emulsion-based formats are used for high-throughput processing, then throughput is increased, but the ability to perform multi-step sequential reactions is limited
Solution Approach 1:
The reaction system is segmented into multiple distinct compartments (droplets or micro-wells), each capable of performing a specific step in the sequential reaction process. This allows different biochemical reactions to occur in separate compartments that can be sequentially accessed or combined, enabling multi-step processing while maintaining high throughput parallelization across many compartments.
Solution Approach 2:
Multiple nested compartments or hierarchical structures are employed where smaller reaction compartments are contained within larger processing environments. This nested architecture allows sequential access to different reaction zones and enables complex multi-step workflows where inner compartments can be manipulated independently while maintaining the overall high-throughput parallel processing capability.
2Measurement precision
If cell lysis is performed for genetic material amplification, then genotypic analysis is enabled, but subsequent enzymatic steps are inhibited or detrimental
Solution Approach 1:
The harmful lysis reagents and cellular debris are extracted or removed from the reaction compartment through buffer exchange, filtration, or separation techniques before introducing enzymes for subsequent amplification steps. This extraction eliminates the inhibitory effects of lysis components while retaining the released genetic material, thereby enabling both genotypic analysis and reliable enzymatic reactions.
Solution Approach 2:
An intermediary buffer or medium is introduced between the cell lysis step and the enzymatic amplification step. This intermediary serves to neutralize or dilute harmful lysis reagents while maintaining the genetic material in a state suitable for enzymatic processing, thus bridging the two incompatible reaction conditions and enabling both genotypic analysis and reliable enzyme function.
3Reliability
If buffer/reagent exchange is performed to remove lysis reagents, then enzymatic steps can proceed, but processing complexity increases
Solution Approach 1:
The system performs buffer exchange and reagent removal through self-service mechanisms such as passive diffusion, gravity-driven flow, or integrated microfluidic structures that automatically facilitate medium replacement without requiring complex external manipulation. This reduces the operational complexity while maintaining the ability to remove harmful reagents and enable reliable enzymatic reactions.
Solution Approach 2:
Flexible membranes or thin film structures are employed to enable controlled exchange of buffers and reagents across compartment boundaries. These flexible structures allow selective permeability and controlled access for medium replacement while maintaining compartment integrity, thereby simplifying the buffer exchange process and reducing fluidic operation complexity compared to rigid or complex fluidic systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The capsules enable high-throughput, massively parallel processing and analysis of biological samples, maintaining encapsulated cells alive for extended periods and supporting multiple temperature cycles, while allowing for efficient genotypic and phenotypic analysis.
Implementation Method 1
causing a separation into inner and outer phases of the fluidic droplet containing the species
Implementation Method 2
inducing the gelation of the outer phase of the fluidic droplet containing the species
Data Source
AI summary
This invention relates to methods and systems for isolation of species in semi-permeable capsules and processing of encapsulated species through series of steps and/or reactions. To produce capsules, first aqueous two-phase system (ATPS) droplets are generated using microfluidics system. Then the hydrogel shell layer is hardened by inducing polymerization. As exemplified in this invention to achieve concentric ATPS droplet formation density-matched PEGDA and Dextran polymer solutions can be used. Once a capsule is formed, its composition can be changed by adding new reagents or replacing out old ones (e.g. by resuspending capsules in desired aqueous solution). The hydrogel shell of semi-permeable capsules can be dissolved at selected step during multi-step procedures to release the encapsulated species. This invention exemplifies isolation of individual cells within capsules and using the encapsulated cells for genotypic and phenotypic analysis. This invention also exemplifies use of capsules in multi-step procedures to perform complex biological reactions.